About inveox
inveox is a company based in Munchen (Germany) founded in 2017 by Maria Driesel and Robin Zuber. inveox has raised $25.81 million across 5 funding rounds from investors including Munich Startup and Für-Gründer.de. inveox offers products and services including Pathology Ecosystem, Intelligent Sample Container, and Digital Invorder System. inveox operates in a competitive market with competitors including Atrys, Evosep, Ovizio, C the Signs and Pressure BioSciences, among others.
- Headquarter Munchen, Germany
- Founders Maria Driesel, Robin Zuber
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Inveox Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$25.81 M (USD)
in 5 rounds
-
Latest Funding Round
$18.88 M (USD), Series A
Aug 05, 2019
-
Investors
Munich Startup
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of inveox
inveox offers a comprehensive portfolio of products and services, including Pathology Ecosystem, Intelligent Sample Container, and Digital Invorder System.
Integrated system for automating histopathology processes and cancer diagnosis.
Secure container for tracking and handling pathology samples accurately.
Tool for registering and managing lab orders in pathology workflows.
People of inveox
Unlock access to complete
Unlock access to complete
Funding Insights of inveox
inveox has successfully raised a total of $25.81M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $18.88 million completed in August 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in inveox
inveox has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Munich Startup and Für-Gründer.de.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A portal for startups in Munich is provided.
|
Locked | Locked | Locked | |
|
An online platform for entrepreneurs is provided by Für-Gründer.de.
|
Locked | Locked | Locked |
Investor details for inveox
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by inveox
Investment portfolio details for inveox
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - inveox
Detailed financials for inveox
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Inveox Comparisons
Peer comparison for inveox
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of inveox
inveox operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Atrys, Evosep, Ovizio, C the Signs and Pressure BioSciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of diagnostic and therapeutic services catering to cancer
|
|
| Locked | Locked | Locked |
Solutions for clinical proteomics sample preparation are developed.
|
|
| Locked | Locked | Locked |
Imaging systems and AI software for microscopes are developed.
|
|
| Locked | Locked | Locked |
Platform offering cancer prediction system for early cancer detection
|
|
| Locked | Locked | Locked |
Biomolecular reactions are controlled via pressure cycling technology.
|
|
| Locked | Locked | Locked |
Wall-less plates and washers are developed for automated cell-based assays.
|
Detailed competitors of inveox
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Inveox
Complete news archive for inveox
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about inveox
inveox was founded in 2017.
inveox is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Maria Driesel is the current CEO of inveox. They have also founded this company.
inveox is a funded company, having raised a total of $25.81M across 5 funding rounds to date.
Inveox was founded in 2017 in Munich, Germany, focusing on the biotechnology sector. Automated laboratory solutions are developed for biopsy sample handling, including transfer, labeling, receipt, and encapsulation of tissue samples. Software for laboratory information management is offered, enabling digital linkage of relevant data via QR codes. An automated device is designed for sample processing, management, and container arrangement.
inveox offers Pathology Ecosystem, Intelligent Sample Container, and Digital Invorder System.
inveox has 2 investors. Key investors include Munich Startup, and Für-Gründer.de.